Estimating the Effects of Continuous Albuterol Dosage on Clinical Outcomes for Pediatric Critical Asthma Exacerbation: A Retrospective Cohort Study
Findings suggest that starting continuous albuterol at 10 mg/h provides clinical outcomes comparable to 15 mg/h in managing pediatric critical asthma exacerbations. A lower starting dose may optimize resource use and reduce treatment-related adverse effects.
Authors
- Daniel P. Riggins (ORCID: https://orcid.org/0000-0002-6240-6212)
- Eneida A. Mendonça (ORCID: https://orcid.org/0000-0003-4297-9221)
- Wanzhu Tu (ORCID: https://orcid.org/0000-0002-4236-9135)
- Colin Rogerson (ORCID: https://orcid.org/0000-0001-5251-2399)
- Lucas Bulgarelli (ORCID: https://orcid.org/0000-0001-5456-2170)
- Patricia Tachinardi
Institutions
- Indiana University Health (US)
- Cincinnati Children's Hospital Medical Center (US)
- Regenstrief Institute (US)
- Indiana University Indianapolis (US)
- Indiana University School of Medicine
- Indiana University – Purdue University Indianapolis (US)
- University of Cincinnati Medical Center (US)
Publication Details
- Journal
- Pediatric Pulmonology
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1002/ppul.71293
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00